Moderna files for full FDA approval of its COVID-19 vaccine

Moderna today asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older. So far, 124 million doses of the Moderna vaccine have been administered in the U.S. Moderna’s request for a priority review of its Biologics License Application includes data submitted on a rolling basis culled from its ongoing phase 3 clinical trial. Moderna is currently tracking about three weeks behind Pfizer, whose application for full FDA approval of its own COVID-19 vaccine was submitted May 7.